Liver Cancer

Proteomics can be useful in researching hepatic diseases

Published in Clinical Oncology Week, June 14th, 2004

Researchers say that that proteomic research techniques may be able to identify proteins as biomarkers in various liver diseases.

"Proteomics has become an important part in the leading research area and been widely used in the disease-associated study," scientists writing in the journal Science in China report.

"In hepatic research field, proteomics could be applied in study of hepatic diseases including liver cancer, cirrhosis, and hepatotoxicities, etc.," wrote W. Sun and colleagues, Beijing Institute of Radiation Medicine.

The researchers concluded: "Significant proteins could be identified as biomarkers, drug targets...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2004-06-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry